Medical News

RSS

Study: Three-drug combination improves overall survival in patients with mCRC

The three-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival (OS) in patients with BRAF-mutated metastatic colorectal cancer (mCRC), according to results of the BEACON CRC Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

30 Sep 2019

UK government considers compulsory immunization for all school children

Immunization efforts have been implemented across the globe. But, the rates of immunized children are dropping. In the United Kingdom, health officials have expressed alarms the drop in take-up of routine childhood vaccinations, leaving thousands of children under-protected from 13 different diseases.

30 Sep 2019

New imaging systems can help diagnose heart disease

Researcher and professor Lasse Løvstakken starts a video on his computer screen. We're in the eye of a storm. It looks almost like a hurricane approaching a coastline.

30 Sep 2019

Nearly half of the flights taken by travellers are pointless, shows research

New research evaluating the necessity of air travel indicates that as many as half of flights may be considered to lack importance to the travellers themselves, according to a study published by the Journal of Air Transport Management.

30 Sep 2019

New method can help detect melanoma cells in skin tumors

Melanoma is the least common but one of the most deadly skin cancers. It accounts for only about one percent of all cases globally, but the majority of skin cancer deaths.

30 Sep 2019

Deer can pass tuberculosis to humans, CDC warns

Tuberculosis or TB is a highly contagious infection that usually affects the lungs, but it can spread to other parts of the body, such as the spine and brain. Commonly caused by Mycobacterium tuberculosis, which can spread through the air from person to person.

30 Sep 2019

Placebos may lead to mistaken inferences about effects and harms of new treatment

Placebo controls are the 'gold' standard against which new treatments are often measured. If a new treatment consistently proves to be better than a placebo treatment, then it is taken to be effective. Otherwise, it isn't.

30 Sep 2019

New screening test detects 20 types of cancer

Researchers from the Dana-Farber Cancer Institute have developed a new blood test that would accurately determine the presence of several types of cancers. The results of their multi-centre clinical trial to prove the effectiveness of their test was presented by the researchers at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, on the 28th of September 2019.

30 Sep 2019

People with severe insomnia may benefit from sedatives, shows study

Insomnia is a driver of suicide, and particularly people with severe insomnia may safely benefit from taking a sedative to help address their sleep problems as it reduces their suicidal thoughts, investigators report.

30 Sep 2019

Many Italian truck drivers suffer from sleep-related breathing problem, shows survey

A survey of 905 Italian truck drivers has shown that approximately half suffer from at least one sleep-related breathing problem that potentially can cause drivers to fall asleep at the wheel.

30 Sep 2019

Study reveals molecular mechanism of cancer malignancy and development of leukemia

A Waseda University-led research uncovered the molecular mechanism of how a particular cancer-causing oncogene could trigger an onset of acute myeloid leukemia (AML).

30 Sep 2019

Study: Heart disease is associated with allopurinol-related severe skin reactions

Heart disease is an independent risk factor for severe adverse skin reactions in patients taking allopurinol, found a study published in CMAJ (Canadian Medical Association Journal).

30 Sep 2019

Higher dosage of statins can increase risk of osteoporosis, shows study

At low doses, statins could protect against bone resorption. But the higher the dosage of cholesterol-lowering drugs, the greater the probability of osteoporosis, an analysis of millions of patient data by the Complexity Science Hub Vienna shows.

30 Sep 2019

US Government supports Kinoxis Therapeutics to end opioid addiction

Kinoxis Therapeutics has been awarded a grant for a potential of up to $US4.6 million ($6.8 million) under the USA National Institutes of Health Helping to End Addiction Long-Term, or the NIH HEAL Initiative.

30 Sep 2019

Nintedanib drug can benefit patients with broad range of scarring lung diseases

Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis, slows the decline in lung function among patients with a broad range of scarring lung diseases.

30 Sep 2019

Nichi-Iko and Eisai sign collaboration deal for generic pharmaceutical business in China

Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have entered into a comprehensive collaboration agreement for the generic pharmaceutical business in China.

30 Sep 2019

Smart shirt technology is a promising tool for monitoring lung disease

A smart shirt that measures lung function by sensing movements in the chest and abdomen has proved to be accurate when compared to traditional testing equipment, according to research presented at the European Respiratory Society International Congress.

30 Sep 2019

Adding targeted therapy drug to standard treatment benefits aggressive breast cancer patients

A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly improve overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common forms of the disease.

29 Sep 2019

Wrist-worn step trackers can be used to determine health status of patients

Determining how far patients with pulmonary disease can walk in six minutes has long been an effective clinical tool to help physicians determine their exercise capacity, as well as to aid in predicting health outcomes and mortality.

29 Sep 2019